Connection

David Bachman to Humans

Back to Details
This is a "connection" page, showing publications David Bachman has written about Humans.
David Bachman
Connection Strength
0.227
Humans
  1. A comparison of four embedded validity indices for the RBANS in a memory disorders clinic. Arch Clin Neuropsychol. 2015 May; 30(3):207-16.
    View in: PubMed
    Score: 0.019
  2. APOE genotype in the diagnosis of Alzheimer's disease in patients with cognitive impairment. Am J Alzheimers Dis Other Demen. 2012 Aug; 27(5):315-20.
    View in: PubMed
    Score: 0.016
  3. Neurocognitive impairment in obstructive sleep apnea. Chest. 2012 Jun; 141(6):1601-1610.
    View in: PubMed
    Score: 0.016
  4. Intact cognition in depressed elderly veterans providing adequate effort. Arch Clin Neuropsychol. 2011 Apr; 26(3):184-93.
    View in: PubMed
    Score: 0.014
  5. Embedded indices of effort in the repeatable battery for the assessment of neuropsychological status (RBANS) in a geriatric sample. Clin Neuropsychol. 2010 Aug; 24(6):1064-77.
    View in: PubMed
    Score: 0.014
  6. Establishment of a predominantly African-American cohort for the study of Alzheimer's disease: the South Carolina Alzheimer's disease clinical core. Dement Geriatr Cogn Disord. 2009; 27(4):329-36.
    View in: PubMed
    Score: 0.013
  7. "Sundowning" and other temporally associated agitation states in dementia patients. Annu Rev Med. 2006; 57:499-511.
    View in: PubMed
    Score: 0.010
  8. Diagnostic challenges of using CSF assay of tau and beta-amyloid(42) in atypical degenerative dementias of the Alzheimer type. Arch Clin Neuropsychol. 2003 Dec; 18(8):893-903.
    View in: PubMed
    Score: 0.009
  9. Comparison of Alzheimer's disease risk factors in white and African American families. Neurology. 2003 Apr 22; 60(8):1372-4.
    View in: PubMed
    Score: 0.008
  10. Firearm presence in households of patients with Alzheimer's disease and related dementias. J Am Geriatr Soc. 1999 Oct; 47(10):1183-6.
    View in: PubMed
    Score: 0.007
  11. Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Cerebrovasc Dis. 2019; 47(1-2):24-31.
    View in: PubMed
    Score: 0.006
  12. Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis? Cerebrovasc Dis. 2017; 43(1-2):31-35.
    View in: PubMed
    Score: 0.005
  13. Oscillating Square Wave Transcranial Direct Current Stimulation (tDCS) Delivered During Slow Wave Sleep Does Not Improve Declarative Memory More Than Sham: A Randomized Sham Controlled Crossover Study. Brain Stimul. 2015 May-Jun; 8(3):528-34.
    View in: PubMed
    Score: 0.005
  14. New approaches in the treatment of Alzheimer's disease. J S C Med Assoc. 1994 Nov; 90(11):553-9.
    View in: PubMed
    Score: 0.005
  15. Antihypertensive medication persistence 1-year post-stroke hospitalization. J Clin Hypertens (Greenwich). 2014 Dec; 16(12):869-74.
    View in: PubMed
    Score: 0.005
  16. The impact of ICD-9 revascularization procedure codes on estimates of racial disparities in ischemic stroke. J Stroke Cerebrovasc Dis. 2014 Nov-Dec; 23(10):2681-2686.
    View in: PubMed
    Score: 0.005
  17. Racial differences in poststroke rehabilitation utilization and functional outcomes. Arch Phys Med Rehabil. 2015 Jan; 96(1):84-90.
    View in: PubMed
    Score: 0.005
  18. Persistent racial disparity in stroke hospitalization and economic impact in young adults in the buckle of stroke belt. Stroke. 2014 Jul; 45(7):1932-8.
    View in: PubMed
    Score: 0.005
  19. Simultaneous optic neuropathy and osmotic demyelinating syndrome in hyperemesis gravidarum. Am J Med Sci. 2014 Jan; 347(1):88-90.
    View in: PubMed
    Score: 0.004
  20. Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial. Int Psychogeriatr. 2014 Feb; 26(2):239-46.
    View in: PubMed
    Score: 0.004
  21. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J Clin Psychiatry. 2013 Aug; 74(8):810-6.
    View in: PubMed
    Score: 0.004
  22. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology. 1993 Mar; 43(3 Pt 1):515-9.
    View in: PubMed
    Score: 0.004
  23. Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET). Am J Geriatr Psychiatry. 2013 Jun; 21(6):549-59.
    View in: PubMed
    Score: 0.004
  24. Sleep disorders with aging: evaluation and treatment. Geriatrics. 1992 Sep; 47(9):53-6, 59-61.
    View in: PubMed
    Score: 0.004
  25. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology. 1992 Jan; 42(1):115-9.
    View in: PubMed
    Score: 0.004
  26. Depressive symptoms following stroke. Am J Psychiatry. 1991 Mar; 148(3):351-6.
    View in: PubMed
    Score: 0.004
  27. Use of seniors as mentors to medical students: a collaboration between the University of South Carolina School of Medicine and the Medical University of South Carolina. J S C Med Assoc. 2011 Feb; 107(1):8-12.
    View in: PubMed
    Score: 0.004
  28. Higher incidence of mild cognitive impairment in familial hypercholesterolemia. Am J Med. 2010 Mar; 123(3):267-74.
    View in: PubMed
    Score: 0.003
  29. Does it stick? Effects of an integrated vertical undergraduate aging curriculum on medical and surgical residents. J Am Geriatr Soc. 2008 Jan; 56(1):132-8.
    View in: PubMed
    Score: 0.003
  30. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007; 22(12):839-69.
    View in: PubMed
    Score: 0.003
  31. Preliminary examination of progression of Alzheimer's disease in a rural Southern African American cohort. Arch Clin Neuropsychol. 2007 Mar; 22(3):405-14.
    View in: PubMed
    Score: 0.003
  32. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol. 2003 May; 60(5):753-9.
    View in: PubMed
    Score: 0.002
  33. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects. Arch Neurol. 2002 Apr; 59(4):594-600.
    View in: PubMed
    Score: 0.002
  34. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA. 2002 Jan 16; 287(3):329-36.
    View in: PubMed
    Score: 0.002
  35. The geographic variation in stroke incidence in two areas of the southeastern stroke belt: the Anderson and Pee Dee Stroke Study. Stroke. 1998 Oct; 29(10):2061-8.
    View in: PubMed
    Score: 0.002
  36. Effectiveness of a continuum of care using brief and partial hospitalization for agitated dementia patients. Psychiatr Serv. 1997 Nov; 48(11):1435-9.
    View in: PubMed
    Score: 0.001
  37. Unawareness of cognitive deficit in Alzheimer disease and related dementias. Alzheimer Dis Assoc Disord. 1997 Sep; 11(3):125-31.
    View in: PubMed
    Score: 0.001
  38. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol. 1995 May; 52(5):485-90.
    View in: PubMed
    Score: 0.001
  39. A new approach for the management of acute psychiatric disorders in elderly demented patients. J S C Med Assoc. 1994 Aug; 90(8):373-6.
    View in: PubMed
    Score: 0.001
  40. Behavioral Intensive Care Unit (BICU): a new concept in the management of acute agitated behavior in elderly demented patients. Gerontologist. 1993 Dec; 33(6):801-6.
    View in: PubMed
    Score: 0.001
  41. Pharmacotherapy for aphasia. Neurology. 1988 Jun; 38(6):877-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.